These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 26987379)

  • 1. Role of enterohepatic recirculation in drug disposition: cooperation and complications.
    Malik MY; Jaiswal S; Sharma A; Shukla M; Lal J
    Drug Metab Rev; 2016 May; 48(2):281-327. PubMed ID: 26987379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enterohepatic circulation: physiological, pharmacokinetic and clinical implications.
    Roberts MS; Magnusson BM; Burczynski FJ; Weiss M
    Clin Pharmacokinet; 2002; 41(10):751-90. PubMed ID: 12162761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficiency of enterohepatic circulation, its determination and influence on drug bioavailability.
    Horkovics-Kovats S
    Arzneimittelforschung; 1999 Oct; 49(10):805-15. PubMed ID: 10554656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A reversible clearance model for the enterohepatic circulation of drug and conjugate metabolite pair.
    Semmes RL; Shen DD
    Drug Metab Dispos; 1990; 18(1):80-7. PubMed ID: 1970782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the Change in the Blood Concentration-Time Profile Caused by Complex Drug-Drug Interactions in the Liver Considering the Enterohepatic Circulation: Examining Whether the Inhibition Constants for Uptake, Metabolism, and Biliary Excretion Can be Recovered by the Analyses Using Physiologically Based Pharmacokinetic Modeling.
    Toshimoto K; Tomoda Y; Chiba K; Sugiyama Y
    J Pharm Sci; 2017 Sep; 106(9):2727-2738. PubMed ID: 28479365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A quantitative enterohepatic circulation model: development and evaluation with tesofensine and meloxicam.
    Lehr T; Staab A; Tillmann C; Trommeshauser D; Schaefer HG; Kloft C
    Clin Pharmacokinet; 2009; 48(8):529-42. PubMed ID: 19705923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A recirculatory model with enterohepatic circulation by measuring portal and systemic blood concentration difference.
    Moriwaki T; Yasui H; Yamamoto A
    J Pharmacokinet Pharmacodyn; 2003 Apr; 30(2):119-44. PubMed ID: 12942684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetic modeling for enterohepatic recirculation in Rhesus monkey.
    Shou M; Lu W; Kari PH; Xiang C; Liang Y; Lu P; Cui D; Emary WB; Michel KB; Adelsberger JK; Brunner JE; Rodrigues AD
    Eur J Pharm Sci; 2005 Oct; 26(2):151-61. PubMed ID: 16085400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population pharmacokinetic modelling of the enterohepatic recirculation of diclofenac and rofecoxib in rats.
    Huntjens DR; Strougo A; Chain A; Metcalf A; Summerfield S; Spalding DJ; Danhof M; Della Pasqua O
    Br J Pharmacol; 2008 Mar; 153(5):1072-84. PubMed ID: 18193075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of human pharmacokinetics-biliary and intestinal clearance and enterohepatic circulation.
    Fagerholm U
    J Pharm Pharmacol; 2008 May; 60(5):535-42. PubMed ID: 18416932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Gallbladder-Based Enterohepatic Circulation Model for Pharmacokinetic Studies.
    Okour M; Brundage RC
    Eur J Drug Metab Pharmacokinet; 2019 Aug; 44(4):493-504. PubMed ID: 30488336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Model systems for pharmacokinetics of steroid drugs subject to enterohepatic circulation.
    Schumann W; Hillesheim HG; Gira G
    Exp Clin Endocrinol; 1986 Jul; 87(2):118-24. PubMed ID: 3758191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A time-lag model for pharmacokinetics of drugs subject to enterohepatic circulation.
    Steimer JL; Plusquellec Y; Guillaume A; Boisvieux JF
    J Pharm Sci; 1982 Mar; 71(3):297-302. PubMed ID: 7069584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enterohepatic circulation of lorazepam and acetaminophen conjugates in ponies.
    Greenblatt DJ; Engelking LR
    J Pharmacol Exp Ther; 1988 Feb; 244(2):674-9. PubMed ID: 3346841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of drugs subject to enterohepatic circulation.
    Chen HS; Gross JF
    J Pharm Sci; 1979 Jun; 68(6):792-4. PubMed ID: 458586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. General treatment of the enterohepatic recirculation of drugs and its influence on the area under the plasma level curves, bioavailability, and clearance.
    Peris-Ribera JE; Torres-Molina F; Garcia-Carbonell MC; Aristorena JC; Granero L
    Pharm Res; 1992 Oct; 9(10):1306-13. PubMed ID: 1448431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asymptotics and bioavailability in multicompartment pharmacokinetic models with enterohepatic circulation.
    Horkovics-Kovats S; Zlatos P
    Math Biosci; 2003 Jul; 184(1):69-99. PubMed ID: 12788234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biliary excretion of drugs in man.
    Rollins DE; Klaassen CD
    Clin Pharmacokinet; 1979; 4(5):368-79. PubMed ID: 389528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating the fraction reabsorbed in drugs undergoing enterohepatic circulation.
    Tse FL; Ballard F; Skinn J
    J Pharmacokinet Biopharm; 1982 Aug; 10(4):455-61. PubMed ID: 7153875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moment analysis of stereoselective enterohepatic circulation and unidirectional chiral inversion of ketoprofen enantiomers in rat.
    Yasui H; Yamaoka K; Nakagawa T
    J Pharm Sci; 1996 Jun; 85(6):580-5. PubMed ID: 8773953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.